nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—pharynx cancer	0.964	1	CbGaD
Lidocaine—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00217	0.0605	CbGpPWpGaD
Lidocaine—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0019	0.053	CbGpPWpGaD
Lidocaine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00122	0.0339	CbGpPWpGaD
Lidocaine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00107	0.0297	CbGpPWpGaD
Lidocaine—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00103	0.0287	CbGpPWpGaD
Lidocaine—CYP2C18—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.001	0.028	CbGpPWpGaD
Lidocaine—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.000904	0.0252	CbGpPWpGaD
Lidocaine—CYP2C18—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00088	0.0245	CbGpPWpGaD
Lidocaine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.000796	0.0222	CbGpPWpGaD
Lidocaine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.000698	0.0194	CbGpPWpGaD
Lidocaine—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000667	0.0186	CbGpPWpGaD
Lidocaine—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000611	0.017	CbGpPWpGaD
Lidocaine—CYP2C18—Biological oxidations—CNDP2—pharynx cancer	0.000589	0.0164	CbGpPWpGaD
Lidocaine—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000585	0.0163	CbGpPWpGaD
Lidocaine—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000536	0.0149	CbGpPWpGaD
Lidocaine—CYP2C18—Biological oxidations—ADH7—pharynx cancer	0.000533	0.0148	CbGpPWpGaD
Lidocaine—EGFR—E-cadherin signaling in keratinocytes—CDH1—pharynx cancer	0.000527	0.0147	CbGpPWpGaD
Lidocaine—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000493	0.0137	CbGpPWpGaD
Lidocaine—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000482	0.0134	CbGpPWpGaD
Lidocaine—CYP2C18—Biological oxidations—ADH1B—pharynx cancer	0.000467	0.013	CbGpPWpGaD
Lidocaine—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000433	0.012	CbGpPWpGaD
Lidocaine—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000423	0.0118	CbGpPWpGaD
Lidocaine—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000418	0.0116	CbGpPWpGaD
Lidocaine—CYP3A7—Biological oxidations—CNDP2—pharynx cancer	0.000392	0.0109	CbGpPWpGaD
Lidocaine—EGFR—Bladder Cancer—CDH1—pharynx cancer	0.000386	0.0107	CbGpPWpGaD
Lidocaine—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.00037	0.0103	CbGpPWpGaD
Lidocaine—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000366	0.0102	CbGpPWpGaD
Lidocaine—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.000359	0.01	CbGpPWpGaD
Lidocaine—CYP3A7—Biological oxidations—ADH7—pharynx cancer	0.000354	0.00987	CbGpPWpGaD
Lidocaine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000343	0.00955	CbGpPWpGaD
Lidocaine—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00034	0.00947	CbGpPWpGaD
Lidocaine—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.000325	0.00905	CbGpPWpGaD
Lidocaine—CYP3A7—Biological oxidations—ADH1B—pharynx cancer	0.000311	0.00866	CbGpPWpGaD
Lidocaine—EGFR—Stabilization and expansion of the E-cadherin adherens junction—CDH1—pharynx cancer	0.000303	0.00843	CbGpPWpGaD
Lidocaine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000301	0.00837	CbGpPWpGaD
Lidocaine—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000298	0.0083	CbGpPWpGaD
Lidocaine—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.000292	0.00812	CbGpPWpGaD
Lidocaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00029	0.00809	CbGpPWpGaD
Lidocaine—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00029	0.00807	CbGpPWpGaD
Lidocaine—EGFR—Bladder Cancer—CCND1—pharynx cancer	0.000288	0.00801	CbGpPWpGaD
Lidocaine—EGFR—a6b1 and a6b4 Integrin signaling—CDH1—pharynx cancer	0.000286	0.00798	CbGpPWpGaD
Lidocaine—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.000285	0.00793	CbGpPWpGaD
Lidocaine—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.000283	0.00789	CbGpPWpGaD
Lidocaine—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—pharynx cancer	0.000272	0.00757	CbGpPWpGaD
Lidocaine—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.000262	0.0073	CbGpPWpGaD
Lidocaine—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.000256	0.00713	CbGpPWpGaD
Lidocaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000255	0.00709	CbGpPWpGaD
Lidocaine—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.000245	0.00683	CbGpPWpGaD
Lidocaine—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00023	0.0064	CbGpPWpGaD
Lidocaine—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.000225	0.00626	CbGpPWpGaD
Lidocaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000224	0.00624	CbGpPWpGaD
Lidocaine—SCN9A—L1CAM interactions—EGFR—pharynx cancer	0.000224	0.00624	CbGpPWpGaD
Lidocaine—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.000222	0.00618	CbGpPWpGaD
Lidocaine—SCN3A—L1CAM interactions—EGFR—pharynx cancer	0.000214	0.00597	CbGpPWpGaD
Lidocaine—SCN4A—L1CAM interactions—EGFR—pharynx cancer	0.000206	0.00573	CbGpPWpGaD
Lidocaine—SCN2A—L1CAM interactions—EGFR—pharynx cancer	0.000206	0.00573	CbGpPWpGaD
Lidocaine—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.000201	0.00561	CbGpPWpGaD
Lidocaine—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.0002	0.00556	CbGpPWpGaD
Lidocaine—SCN10A—L1CAM interactions—EGFR—pharynx cancer	0.000198	0.00553	CbGpPWpGaD
Lidocaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000197	0.00548	CbGpPWpGaD
Lidocaine—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.000195	0.00542	CbGpPWpGaD
Lidocaine—EGFR—Gastric Cancer Network 2—TP53—pharynx cancer	0.000189	0.00528	CbGpPWpGaD
Lidocaine—EGFR—Bladder Cancer—TP53—pharynx cancer	0.000189	0.00528	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—CCND1—pharynx cancer	0.000184	0.00514	CbGpPWpGaD
Lidocaine—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.000182	0.00507	CbGpPWpGaD
Lidocaine—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.000181	0.00503	CbGpPWpGaD
Lidocaine—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.000171	0.00475	CbGpPWpGaD
Lidocaine—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00016	0.00445	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—CD79A—pharynx cancer	0.000159	0.00443	CbGpPWpGaD
Lidocaine—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.000158	0.00441	CbGpPWpGaD
Lidocaine—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.000154	0.0043	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Telomerase—CCND1—pharynx cancer	0.000153	0.00427	CbGpPWpGaD
Lidocaine—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.000153	0.00426	CbGpPWpGaD
Lidocaine—SCN5A—L1CAM interactions—EGFR—pharynx cancer	0.000139	0.00389	CbGpPWpGaD
Lidocaine—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.000135	0.00377	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.000132	0.00368	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.000132	0.00367	CbGpPWpGaD
Lidocaine—EGFR—Androgen receptor signaling pathway—CCND1—pharynx cancer	0.000124	0.00345	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—TP53—pharynx cancer	0.000122	0.00338	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.000119	0.00332	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.000109	0.00303	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000104	0.00291	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.000102	0.00285	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CNDP2—pharynx cancer	0.000101	0.00281	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—CCND1—pharynx cancer	9.87e-05	0.00275	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ADH7—pharynx cancer	9.11e-05	0.00254	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	8.7e-05	0.00242	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—EGFR—pharynx cancer	8.46e-05	0.00236	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	8.1e-05	0.00226	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—EGFR—pharynx cancer	8.09e-05	0.00225	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ADH1B—pharynx cancer	7.99e-05	0.00223	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—EGFR—pharynx cancer	7.78e-05	0.00217	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—EGFR—pharynx cancer	7.78e-05	0.00217	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—B4GALT5—pharynx cancer	7.64e-05	0.00213	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—EGFR—pharynx cancer	7.5e-05	0.00209	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—CCND1—pharynx cancer	6.74e-05	0.00188	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	6.71e-05	0.00187	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CNDP2—pharynx cancer	6.7e-05	0.00187	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	6.63e-05	0.00185	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	6.63e-05	0.00185	CbGpPWpGaD
Lidocaine—EGFR—Disease—B4GALT5—pharynx cancer	6.55e-05	0.00183	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TP53—pharynx cancer	6.5e-05	0.00181	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD79A—pharynx cancer	6.41e-05	0.00179	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CNDP2—pharynx cancer	6.14e-05	0.00171	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ADH7—pharynx cancer	6.06e-05	0.00169	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EGFR—pharynx cancer	6.04e-05	0.00168	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EGFR—pharynx cancer	5.78e-05	0.00161	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—pharynx cancer	5.67e-05	0.00158	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ADH7—pharynx cancer	5.55e-05	0.00155	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EGFR—pharynx cancer	5.55e-05	0.00155	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EGFR—pharynx cancer	5.55e-05	0.00155	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EGFR—pharynx cancer	5.35e-05	0.00149	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—pharynx cancer	5.34e-05	0.00149	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ADH1B—pharynx cancer	5.31e-05	0.00148	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—pharynx cancer	5.27e-05	0.00147	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—B4GALT5—pharynx cancer	5.08e-05	0.00141	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CNDP2—pharynx cancer	4.96e-05	0.00138	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—pharynx cancer	4.9e-05	0.00137	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ADH1B—pharynx cancer	4.87e-05	0.00136	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CNDP2—pharynx cancer	4.84e-05	0.00135	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—B4GALT5—pharynx cancer	4.65e-05	0.0013	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ADH7—pharynx cancer	4.48e-05	0.00125	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	4.42e-05	0.00123	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ADH7—pharynx cancer	4.38e-05	0.00122	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CNDP2—pharynx cancer	4.2e-05	0.00117	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ADH1B—pharynx cancer	3.93e-05	0.00109	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD79A—pharynx cancer	3.89e-05	0.00108	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ADH1B—pharynx cancer	3.84e-05	0.00107	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ADH7—pharynx cancer	3.79e-05	0.00106	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—pharynx cancer	3.76e-05	0.00105	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—B4GALT5—pharynx cancer	3.76e-05	0.00105	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—B4GALT5—pharynx cancer	3.67e-05	0.00102	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CNDP2—pharynx cancer	3.65e-05	0.00102	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDH1—pharynx cancer	3.57e-05	0.000995	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CNDP2—pharynx cancer	3.44e-05	0.000959	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CNDP2—pharynx cancer	3.41e-05	0.000951	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	3.39e-05	0.000944	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ADH1B—pharynx cancer	3.33e-05	0.000927	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ADH7—pharynx cancer	3.31e-05	0.000921	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—B4GALT5—pharynx cancer	3.18e-05	0.000886	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ADH7—pharynx cancer	3.11e-05	0.000868	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ADH7—pharynx cancer	3.09e-05	0.00086	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CNDP2—pharynx cancer	2.92e-05	0.000813	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ADH1B—pharynx cancer	2.9e-05	0.000807	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—B4GALT5—pharynx cancer	2.77e-05	0.000772	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ADH1B—pharynx cancer	2.73e-05	0.000761	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ADH1B—pharynx cancer	2.71e-05	0.000754	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	2.66e-05	0.000741	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ADH7—pharynx cancer	2.64e-05	0.000735	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—B4GALT5—pharynx cancer	2.61e-05	0.000727	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—B4GALT5—pharynx cancer	2.59e-05	0.000721	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ADH1B—pharynx cancer	2.31e-05	0.000645	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CNDP2—pharynx cancer	2.25e-05	0.000627	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	2.23e-05	0.000622	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—B4GALT5—pharynx cancer	2.21e-05	0.000616	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDH1—pharynx cancer	2.17e-05	0.000603	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADH7—pharynx cancer	2.04e-05	0.000567	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADH1B—pharynx cancer	1.79e-05	0.000497	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—B4GALT5—pharynx cancer	1.71e-05	0.000475	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—pharynx cancer	1.04e-05	0.000291	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—pharynx cancer	6.88e-06	0.000192	CbGpPWpGaD
